Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “AstraZeneca”

A Study to Investigate the Impact of Multiple Doses of Itraconazole on AZD5004 in Healthy Participants and Multiple Doses of AZD5004 on Combined Oral Ethinyl Oestradiol and Levonorgestrel in Healthy Female ParticipantsCompleted
NCT06942936Phase 1Updated Feb 3, 2026
Sponsor: AstraZeneca
Healthy Participants
United States, Germany
Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular CarcinomaRecruiting
NCT06904170Phase 2, Phase 3Updated Feb 3, 2026
Sponsor: UNICANCER
Hepatocellular Carcinoma
France
Safety and Tolerability of AZD5148 in Japanese ParticipantsCompleted
NCT06639997Phase 1Updated Jan 30, 2026
Sponsor: AstraZeneca
Clostridioides Difficile Infection
Japan
A Study of Dapagliflozin in Chinese Adult Patients With Chronic Kidney DiseaseActive Not Recruiting
NCT06610526Phase 4Updated Jan 30, 2026
Sponsor: AstraZeneca
Chronic Kidney Disease
China
National Register of Actionable MutationsActive Not Recruiting
NCT05918666N/AUpdated Jan 30, 2026
Sponsor: Federation of Italian Cooperative Oncology Groups
Solid Tumours in Advanced Stages
Italy
Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell LymphomasActive Not Recruiting
NCT05583149Phase 2Updated Jan 29, 2026
Sponsor: Patrick C. Johnson, MD
Refractory Aggressive B-cell Lymphomas · Refractory B-Cell Non-Hodgkin Lymphoma · Aggressive B-cell NHL · Diffuse Large B-cell Lymphoma (DLBCL)
United States
A 12-week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS)Completed
NCT05755906Phase 3Updated Jan 28, 2026
Sponsor: AstraZeneca
Asthma
United States, Canada, Czechia, Malaysia, Philippines +2 more
A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS)Completed
NCT05202262Phase 3Updated Jan 28, 2026
Sponsor: AstraZeneca
Asthma
United States, Canada, Germany, Italy, Japan +2 more
Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell TumorsActive Not Recruiting
NCT03158064Phase 2Updated Jan 28, 2026
Sponsor: Memorial Sloan Kettering Cancer Center
Germ Cell Tumor · Nonseminomatous Germ Cell Tumor · Seminoma · Germinomatous Germ Cell Tumor
United States
Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal PolyposisCompleted
NCT04851964Phase 3Updated Jan 27, 2026
Sponsor: AstraZeneca
Chronic Rhinosinusitis With Nasal Polyps
United States, Canada, China, Denmark, Germany +5 more
A Placebo-controlled Safety and Tolerability Study of Intravenous (IV) and Subcutaneous (SC) AZD1163 in Healthy VolunteersCompleted
NCT06103877Phase 1Updated Jan 27, 2026
Sponsor: AstraZeneca
Healthy Volunteers
United States, Germany
PT027 Compared to PT007 in Patients With Asthma With Mannitol-induced Acute Airway ObstructionCompleted
NCT05555290Phase 3Updated Jan 27, 2026
Sponsor: AstraZeneca
Asthma
United States
A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Oral AZD0233 Compared With Placebo in Healthy Adult Participants.Terminated
NCT06381466Phase 1Updated Jan 26, 2026
Sponsor: AstraZeneca
Dilated Cardiomyopathy
United States
A Study of Lung Cancer Screening in People With Unexplained Weight LossRecruiting
NCT06717334N/AUpdated Jan 23, 2026
Sponsor: Memorial Sloan Kettering Cancer Center
Lung Cancer Screening
United States
Longitudinal Study for Eosinophilic Granulomatosis With PolyangiitisRecruiting
NCT00315380N/AUpdated Jan 23, 2026
Sponsor: University of Pennsylvania
Eosinophilic Granulomatosis With Polyangiitis · Churg-Strauss Syndrome
United States, Canada, Germany, Italy, United Kingdom
DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural MesotheliomaCompleted
NCT04334759Phase 3Updated Jan 22, 2026
Sponsor: PrECOG, LLC.
Mesothelioma · Pleural Mesothelioma · Malignant Pleural Mesothelioma
United States, Australia, New Zealand
dMAbs for Prevention of COVID-19Completed
NCT05293249Phase 1Updated Jan 22, 2026
Sponsor: Pablo Tebas
Healthy Volunteers
United States
Patient Characteristics, Treatment Patterns and Outcomes of Patients With Severe Asthma Treated With Tezepelumab in the Real World; a Retrospective, Observational Medical Chart Review Conducted in UK Severe Asthma CentresCompleted
NCT06455462N/AUpdated Jan 21, 2026
Sponsor: AstraZeneca
Severe Asthma
United Kingdom
Avo In R/R And Previously Untreated MCLRecruiting
NCT04855695Phase 1, Phase 2Updated Jan 21, 2026
Sponsor: Austin I Kim
Mantle Cell Lymphoma · Refractory Lymphoma
United States
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal MalignanciesRecruiting
NCT03539822Phase 1, Phase 2Updated Jan 21, 2026
Sponsor: Anwaar Saeed
Gastric Cancer · Esophageal Adenocarcinoma · Hepatocellular Carcinoma · Colorectal Cancer
United States
Randomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endometrial CancerRecruiting
NCT06712472Phase 3Updated Jan 20, 2026
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Endometrial Cancer · p53abn
France
A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCKCompleted
NCT06269484Phase 2Updated Jan 20, 2026
Sponsor: AstraZeneca
Liver Cirrhosis
United States, Australia, Belgium, Czechia, Germany +5 more
Targeted Assessment in High-Risk paTients With dIAbetes to ideNtify Undiagnosed Heart FailureActive Not Recruiting
NCT05705869NAUpdated Jan 14, 2026
Sponsor: NHS Greater Glasgow and Clyde
Heart Failure · Diabetes Mellitus · Type 1 Diabetes · Type 2 Diabetes
United Kingdom
GC012F Injection in Refractory Idiopathic Inflammatory MyopathyRecruiting
NCT07086404EARLY_Phase 1Updated Jan 14, 2026
Sponsor: Daishi Tian
Idiopathic Inflammatory Myopathy (IIM)
China
LYNPARZA Pancreas Cancer Japan Post-Marketing Surveillance (PMS)Completed
NCT04889404N/AUpdated Jan 14, 2026
Sponsor: AstraZeneca
Pancreatic Neoplasms
Japan

Previous page Next page